Literature DB >> 32491923

Administration of rectal cytotec versus rectal buscopan before hysteroscopy.

Ayse Filiz Gokmen Karasu1, Serdar Aydin1, Seda Ates1, Taha Takmaz1, Cihan Comba2.   

Abstract

INTRODUCTION: Our objective was to compare the effect of rectal misoprostol (Cytotec) versus rectal hyoscine-n-butyl bromide (Buscopan) on patients undergoing hysteroscopy. We hypothesised that HBB may have a role in cervical priming.
MATERIAL AND METHODS: This trial was conducted at Bezmialem Vakif University Hospital. Women of reproductive age between 18-50 years who were scheduled for operative hysteroscopy indicated by type 1 submucous myoma or endometrial polyps were recruited for the study. Ninety patients were divided randomly into three groups. Group 1 received placebo treatment. Group 2 received rectal 200 mcg misoprostol and Group 3 received rectal 20 mg hyoscine-n-butyl bromide two hours before the procedure. Procedures were performed using a bipolar 26 F (9 mm) continuous-flow rigid resectoscope with a 30° lens. The outcome measures included cervical dilation width and time, ease of cervical dilation, procedure time and operative complications. Postoperative self-rated pain was assessed one hour after the procedure.
RESULTS: Thirteen patients (43. 3%) in the placebo treatment group, 11 patients (36.7%) in the misoprostol group and four patients (13.3%) in the hyoscine-n-butyl bromide group needed analgesics postoperatively (p = .02). The mean duration of cervical dilation time was longest in Group 1 and shortest in Group 3, however this difference did not reach statistical significance (p=.11). There was no difference with regard to other studied parameters.
SUMMARY: HBB reduced the need for pain medication compared to placebo. Larger studies are needed to further investigate the role of HBB in facilitating pre-operative cervical priming.

Entities:  

Keywords:  Hysteroscopycervical priming pain hyoscine-n-butyl bromide; misoprostol

Mesh:

Substances:

Year:  2020        PMID: 32491923     DOI: 10.1080/13645706.2020.1748059

Source DB:  PubMed          Journal:  Minim Invasive Ther Allied Technol        ISSN: 1364-5706            Impact factor:   2.442


  3 in total

1.  Diclofenac Potassium Alone Versus Diclofenac Potassium with Hyoscine-N-butyl Bromide (HBB) in Reduction of Pain in Women Undergoing Office Hysteroscopy: A Double Blind Randomized, Placebo-Controlled Trial.

Authors:  Ahmed S S A Rashwan; Mahmoud Alalfy; Sarah Aboubakr Elkomaty; Omneya Mostafa Helal; Eman Aly Hussein
Journal:  J Obstet Gynaecol India       Date:  2022-04-13

2.  Efficacy of hyoscine in pain management during hysteroscopy: a systematic review and meta-analysis

Authors:  Greg J. Marchand; Wesam Kurdi; Katelyn Sainz; Hiba Maarouf; Kelly Ware; Ahmed Taher Masoud; Alexa King; Stacy Ruther; Giovanna Brazil; Kaitlynne Cieminski; Nicolas Calteux; Hollie Ulibarri; Julia Parise; Amanda Arroyo; Diana Chen; Maria Pierson; Rasa Rafie; Mohammad Abrar Shareef
Journal:  J Turk Ger Gynecol Assoc       Date:  2021-12-06

Review 3.  Pain Management during Office Hysteroscopy: An Evidence-Based Approach.

Authors:  Giovanni Buzzaccarini; Luis Alonso Pacheco; Amerigo Vitagliano; Sergio Haimovich; Vito Chiantera; Péter Török; Salvatore Giovanni Vitale; Antonio Simone Laganà; Jose Carugno
Journal:  Medicina (Kaunas)       Date:  2022-08-20       Impact factor: 2.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.